Community Care Consortium (CCC)
BehavioralThe intervention will train community health workers to take an active role in the drug control and addiction service delivery in the community.
NCT Number: NCT05315492
This study aims to develop and test an intervention to enhance the addiction service continuum with the joint effort of commune health workers and family members of people who use drugs in Vietnam.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
National Institute of Hygiene and Epidemiology, Hanoi, Vietnam
The study will develop and test an intervention to strengthen a continuum of addiction services. The intervention, entitled "Community Care Consortium (CCC)," features community health workers' joint effort with family members to provide patient-centered, individualized addiction care and support. The intervention will be developed and tested through three phases in three regions of Vietnam (Ninh Binh, Da Nang, and Can Tho).
In Phase 1, we will conduct formative studies with commune (community) health workers (CHW), community representatives, PWUD, and their family members to identify barriers to addiction service utilization and discuss potential strategies to establish a continuum of addiction services. Based on the formative study findings, the CCC Intervention and its implementation plans will be developed through workgroup meetings with researchers, community members, and target users.
In Phase 2, the CCC Intervention will be piloted in three communes and revised based on acceptability/feasibility data, process evaluation, and feedback from field staff and participants.
In Phase 3, a randomized controlled trial of the CCC Intervention will be conducted in 60 communes, which will be randomized to either an intervention condition or a control condition (30 communes in each condition). A total of 720 PWUD, 720 of their family members, and 180 commune health workers (CHW) will participate in the study. The intervention outcomes on PWUD, CHW, and family members will be assessed with the data collected at baseline, 3-, 6-, 9- and 12-month follow-ups.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention will train community health workers to take an active role in the drug control and addiction service delivery in the community.
Time frame: Changes from baseline to 3-, 6-, 9- and 12- month follow-ups
This overall score consists of individual indicators in 4 domains: Seek,Test, Treat, Retain
Time frame: Changes from baseline to 3-, 6-, 9- and 12- month follow-ups
CHW's service provision and support such as patient referrals and support for treatment retention measured by frequencies of appointment reminder, follow-up activities
Time frame: Changes from baseline to 3-, 6-, 9- and 12- month follow-ups
Family member's emotional, informational, monetary support, logistic assistance for PWUD treatment and retention as well as scale measures in their caregiver burden and coping.
University of California, Los Angeles
Other
Strengthening Addiction Care Continuum Through Community Consortium in Vietnam
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05343793
Addiction, Opioid, Chemically-Induced Disorders
Olympia, Washington, United States
View Trial DetailsNCT06540105
Addiction, Opioid, Chemically-Induced Disorders
La Jolla, California, United States
View Trial DetailsNCT07549126
Chemically-Induced Disorders, Clinical Decision Support
Guilford, Connecticut, United States
View Trial DetailsNCT07737652
Anxiety, Anxiety Disorders
Tuscaloosa, Alabama, United States
View Trial Details